Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

178
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
178
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

415
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
415
Neural Regulation01:37

Neural Regulation

39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep Brain Stimulation of the Internal Pallidum Modulates the Mesencephalic Locomotor Pathway in Improved Cervical Dystonic Patients.

Movement disorders clinical practice·2026
Same author

Dopamine and the dynamics of subthalamic and leg muscle activities in parkinsonian stepping.

Brain : a journal of neurology·2025
Same author

Cortical and Corticomuscular Beta-Gamma Phase-Amplitude Coupling During Different Locomotion States and the Effects of Levodopa in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Deep Learning on Histologic Slides Accurately Predicts Consensus Molecular Subtypes and Spatial Heterogeneity in Colon Cancer.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same author

Subthalamic Electrophysiological Mapping of Gait Initiation Dynamics and Freezing in Parkinson's Disease.

Annals of neurology·2025
Same author

Changes in cortical beta power predict motor control flexibility, not vigor.

Communications biology·2025

Related Experiment Video

Updated: May 23, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.2K

Subthalamic Activity Is Associated With Proactive Inhibition in Parkinson's Disease Patients.

Luna Damiani1, Marion Albares1, Pauline Laviron2

  • 1Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, APHP, Paris, France.

The European Journal of Neuroscience
|March 10, 2025
PubMed
Summary

Subthalamic nucleus (STN) low-frequency activity increases with dopamine treatment and response uncertainty in Parkinson's disease (PD) patients, potentially aiding response inhibition. This contrasts with beta band activity, suggesting a complementary role in regulating behavior.

Keywords:
basal gangliadopamineelectrophysiologyexecutive functionmotor control

More Related Videos

Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
12:04

Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery

Published on: January 6, 2011

12.9K
A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

14.6K

Related Experiment Videos

Last Updated: May 23, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.2K
Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
12:04

Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery

Published on: January 6, 2011

12.9K
A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

14.6K

Area of Science:

  • Neuroscience
  • Movement Disorders
  • Neurophysiology

Background:

  • The subthalamic nucleus (STN) is crucial in the basal ganglia's indirect pathway, targeted for Parkinson's disease (PD) motor symptom relief via deep brain stimulation (DBS).
  • Dopamine depletion in PD increases basal ganglia inhibitory output, but STN's exact role in movement inhibition remains unclear.
  • Understanding STN function in response inhibition is vital for refining PD treatments.

Purpose of the Study:

  • To investigate the relationship between STN local field potentials (LFPs) and response inhibition during varying uncertainty in Parkinson's disease patients.
  • To explore the distinct roles of low-frequency band (LFB) and beta band activity in the STN during a modified Go/NoGo task.

Main Methods:

  • A modified Go/NoGo task was administered to 19 Parkinson's disease patients with STN-DBS implants.
  • STN local field potentials were recorded during the task, with specific attention to low-frequency band (2-7 Hz) and beta band (12-30 Hz) power.
  • Task parameters manipulated uncertainty regarding response execution or withholding.

Main Results:

  • Dopamine treatment significantly increased LFB power, which was further elevated during response uncertainty.
  • Increased LFB power correlated with faster reaction times, suggesting a role in facilitating responses.
  • Beta band power showed an inverse pattern, decreasing with dopamine treatment and increasing with response certainty, correlating with slower reaction times.

Conclusions:

  • STN low-frequency activity may complement beta band activity in regulating inhibitory control, particularly in uncertain situations.
  • STN LFB activity could serve as a biomarker for response inhibition regulation in Parkinson's disease.
  • These findings offer insights into the complex neural mechanisms underlying movement control and inhibition in PD.